Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003)

Clinical trial NCT06799234 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06799234
Sponsor: University of Oxford
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Rift Valley Fever

Start date: 2025-07-08
Primary completion: 2026-03-31
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.